{"id":162357,"date":"2022-05-23T01:48:19","date_gmt":"2022-05-23T05:48:19","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/results-of-the-votes-of-the-combined-shareholders-meeting-of-may-19-2022\/"},"modified":"2024-08-18T11:44:33","modified_gmt":"2024-08-18T15:44:33","slug":"results-of-the-votes-of-the-combined-shareholders-meeting-of-may-19-2022","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/results-of-the-votes-of-the-combined-shareholders-meeting-of-may-19-2022.php","title":{"rendered":"Results of the votes of the Combined Shareholders\u2019 Meeting  of May 19, 2022"},"content":{"rendered":"<p><![CDATA[Daix (France), Long Island City (New York, United States), May 20, 2022 \u2013 Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases with unmet medical need, \u00a0today announced the results of the votes of its Combined Shareholders\u2019 Meeting.]]><\/p>\n<p>See the rest here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/05\/20\/2447917\/0\/en\/Results-of-the-votes-of-the-Combined-Shareholders-Meeting-of-May-19-2022.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Results of the votes of the Combined Shareholders\u2019 Meeting  of May 19, 2022\">Results of the votes of the Combined Shareholders\u2019 Meeting  of May 19, 2022<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the rest here: Results of the votes of the Combined Shareholders\u2019 Meeting of May 19, 2022 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/results-of-the-votes-of-the-combined-shareholders-meeting-of-may-19-2022.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162357","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162357"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162357"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162357\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}